InterCure Reviews US medical cannabis Opportunities
InterCure reviews US medical cannabis after federal rescheduling to Schedule III; Botanico deal adds U.S. genetics, AI production tech and brand alliances.
Cannabis news, weed news, marijuana news
InterCure reviews US medical cannabis after federal rescheduling to Schedule III; Botanico deal adds U.S. genetics, AI production tech and brand alliances.